BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25742197)

  • 1. Correlation of clinical profile and specific histopathological features of temporal artery biopsies.
    Stacy RC; Gilbert AL; Rizzo JF
    J Neuroophthalmol; 2015 Jun; 35(2):127-33. PubMed ID: 25742197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between histological features in temporal artery biopsies and clinical features of patients with giant cell arteritis.
    Breuer GS; Nesher R; Reinus K; Nesher G
    Isr Med Assoc J; 2013 Jun; 15(6):271-4. PubMed ID: 23882888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis.
    Quinn EM; Kearney DE; Kelly J; Keohane C; Redmond HP
    Ann Vasc Surg; 2012 Jul; 26(5):649-54. PubMed ID: 22285348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis.
    Breuer GS; Nesher R; Nesher G
    Clin Exp Rheumatol; 2008; 26(6):1103-6. PubMed ID: 19210879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated to temporal artery biopsy result in suspects of giant cell arteritis: a retrospective, multicenter, case-control study.
    González-López JJ; González-Moraleja J; Burdaspal-Moratilla A; Rebolleda G; Núñez-Gómez-Álvarez MT; Muñoz-Negrete FJ
    Acta Ophthalmol; 2013 Dec; 91(8):763-8. PubMed ID: 22938720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.
    Muratore F; Boiardi L; Cavazza A; Aldigeri R; Pipitone N; Restuccia G; Bellafiore S; Cimino L; Salvarani C
    J Autoimmun; 2016 May; 69():94-101. PubMed ID: 27009904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
    Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
    Clin Rheumatol; 2016 Jul; 35(7):1817-22. PubMed ID: 26925851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of glucocorticoid therapy: before or after temporal artery biopsy?
    Younge BR; Cook BE; Bartley GB; Hodge DO; Hunder GG
    Mayo Clin Proc; 2004 Apr; 79(4):483-91. PubMed ID: 15065613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of unilateral temporal artery biopsy.
    Hall JK; Volpe NJ; Galetta SL; Liu GT; Syed NA; Balcer LJ
    Ophthalmology; 2003 Mar; 110(3):543-8; discussion 548. PubMed ID: 12623818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.
    Gonzalez-Gay MA; Garcia-Porrua C; Llorca J; Gonzalez-Louzao C; Rodriguez-Ledo P
    Semin Arthritis Rheum; 2001 Feb; 30(4):249-56. PubMed ID: 11182025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis.
    Diaz VA; DeBroff BM; Sinard J
    Ophthalmology; 2005 Jul; 112(7):1293-8. PubMed ID: 15921755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of discordant temporal artery biopsy in the diagnosis of giant cell arteritis.
    Durling B; Toren A; Patel V; Gilberg S; Weis E; Jordan D
    Can J Ophthalmol; 2014 Apr; 49(2):157-61. PubMed ID: 24767221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal small-vessel inflammation in patients with giant cell arteritis: clinical course and preliminary immunohistopathologic characterization.
    Belilos E; Maddox J; Kowalewski RM; Kowalewska J; Turi GK; Nochomovitz LE; Khan Y; Carsons SE
    J Rheumatol; 2011 Feb; 38(2):331-8. PubMed ID: 21123318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of biopsy-proven giant cell arteritis in South Australia.
    Dunstan E; Lester SL; Rischmueller M; Dodd T; Black R; Ahern M; Cleland LG; Roberts-Thomson P; Hill CL
    Intern Med J; 2014 Jan; 44(1):32-9. PubMed ID: 24118799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporary artery biopsy in suspected temporal arteritis: a five year survey.
    Stuart RA
    N Z Med J; 1989 Aug; 102(874):431-3. PubMed ID: 2761890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss.
    Chatelain D; Duhaut P; Schmidt J; Loire R; Bosshard S; Guernou M; Pellet H; Piette JC; Sevestre H; Ducroix JP;
    Ann Rheum Dis; 2009 Jan; 68(1):84-8. PubMed ID: 18252763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspected giant cell arteritis: a study of referrals for temporal artery biopsy.
    Moutray TN; Williams MA; Best JL
    Can J Ophthalmol; 2008 Aug; 43(4):445-8. PubMed ID: 18711459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus triggers the immunopathology of giant cell arteritis.
    Gilden D; Nagel MA
    Curr Opin Rheumatol; 2016 Jul; 28(4):376-82. PubMed ID: 27224742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.